R. Sultana

Publications164
h-index70
Citations15,424
Highly Influential Citations499
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • D. Butterfield
  • 473 Publications, 36,945 Citations
  • W. Markesbery
  • 476 Publications, 53,233 Citations
  • D. Butterfield
  • 249 Publications, 13,442 Citations
  • V. Calabrese
  • 199 Publications, 13,542 Citations
  • Publications
  • Influence
The Transcriptional Landscape of the Mammalian Genome
This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We… Expand
  • 3,032
  • 86
  • PDF
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.
SIGNIFICANCE Alzheimer disease (AD) is an age-related neurodegenerative disease. AD is characterized by progressive cognitive impairment. One of the main histopathological hallmarks of AD brain is… Expand
  • 321
  • 20
  • PDF
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach
Nitric oxide (NO) has been implicated in the pathophysiology of a number of neurodegenerative diseases including Alzheimer's disease (AD). In the present study, using a proteomics approach, we… Expand
  • 318
  • 14
  • PDF
Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.
Nanoceria is used as a catalyst in diesel fuel, as an abrasive in printed circuit manufacture, and is being pursued as an antioxidant therapeutic. Our objective is to extend previous findings showing… Expand
  • 103
  • 12
  • PDF
Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.
Lipid peroxidation involves a cascade of reactions in which production of free radicals occurs selectively in the lipid components of cellular membranes. Polyunsaturated fatty acids easily undergo… Expand
  • 271
  • 10
  • PDF
Glutathione elevation by γ‐glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for…
Oxidative stress in heart and brain by the cancer chemotherapeutic drug adriamycin (ADR), used for treating solid tumors, is well established. Long‐term treatment with ADR in breast cancer patients… Expand
  • 102
  • 10
  • PDF
Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
Alzheimer's disease, an age-related neurodegenerative disorder, is characterized clinically by a progressive loss of memory and cognitive functions. Neuropathologically, Alzheimer's disease is… Expand
  • 331
  • 9
  • PDF
Adriamycin-induced, TNF-α-mediated central nervous system toxicity
The clinical effectiveness of adriamycin (ADR), a potent chemotherapeutic, is known to be limited by severe cardiotoxic side effects. However, the effect of ADR on brain tissue is not well… Expand
  • 137
  • 9
Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease
Alzheimer's disease (AD) brains are characterized by accumulation of amyloid beta protein (Abeta) and neuroinflammation. Increased blood-to-brain influx and decreased brain-to-blood efflux across the… Expand
  • 175
  • 9
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD
Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles, senile plaques and loss of synapses. There is accumulating evidence that oxidative stress plays an important role… Expand
  • 290
  • 8
  • PDF